Review The lancet. Gastroenterology & hepatology · 2026 Rifaximin in cirrhosis: when therapeutic drift meets antimicrobial stewardship. Jalan R, Patel VC, Shoaie S Enterococcus faecium PubMed ↗
Observational Journal of gastroenterology and hepatology · 2026 Gut Microbiome Signatures Differ in Cirrhosis With and Without Hepatocellular Carcinoma in a Southeast Asian Cohort. Jinato T, Sikaroodia M, Gilleveta PM, et al. Mediterraneibacter gnavus PubMed ↗
Randomized trial Canadian journal of gastroenterology & hepatology · 2026 Rifaximin Plus Probiotics Reshape Gut Microbiota, Serum Propionate, and Mucosal Immunity in Cirrhosis-Related Hepatic Encephalopathy Microbiota-Immune Remodeling in HE. Wang Y, Zhu H, Wang S, et al. Bacteroides ovatusLigilactobacillus salivarius PubMed ↗
Randomized trial Liver international · 2025 A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention. Vega-Abellaneda S, Román E, Soler Z, et al. Akkermansia muciniphilaStreptococcus thermophilus PubMed ↗
Observational Clinical and translational gastroenterology · 2025 Fecal Microbiota and Bile Acid Profiles in Early-Stage Hepatocellular Carcinoma: A Matched Case-Control Study. Nobel YR, Park H, Tillman AM, et al. Klebsiella pneumoniae PubMed ↗
Observational mSphere · 2025 Small amounts of misassembly can have disproportionate effects on pangenome-based metagenomic analyses. Majernik SN, Beaver L, Bradley PH Lachnospira eligens PubMed ↗
Randomized trial Clinical nutrition ESPEN · 2024 Probiotics may be useful for drug-induced liver dysfunction in patients with depression - A secondary analysis of a randomized clinical trial. Gawlik-Kotelnicka O, Burzyński J, Rogalski J, et al. Bifidobacterium longum PubMed ↗
Observational Clinical and molecular hepatology · 2024 Gut microbiome and metabolome signatures in liver cirrhosis-related complications. Sharma SP, Gupta H, Kwon GH, et al. [Clostridium] symbiosumBacteroides ovatusMediterraneibacter gnavus PubMed ↗
Review Journal of gastroenterology · 2024 Gut microbiota and metabolites of cirrhotic portal hypertension: a novel target on the therapeutic regulation. Hao Y, Hao Z, Zeng X, et al. Alistipes putredinisRoseburia faecisVeillonella dispar PubMed ↗
Randomized trial The Journal of nutrition · 2023 Probiotic Supplementation, Hepatic Fibrosis, and the Microbiota Profile in Patients with Nonalcoholic Steatohepatitis: A Randomized Controlled Trial. Escouto GS, Port GZ, Tovo CV, et al. Bifidobacterium animalis PubMed ↗
Review Frontiers of medicine · 2022 Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives. Han Y, Li L, Wang B Akkermansia muciniphila PubMed ↗
Observational AIDS · 2022 A pilot study of microbial signatures of liver disease in those with HIV mono-infection in Rio de Janeiro, Brazil. Yanavich C, Perazzo H, Li F, et al. Agathobacter rectalisAkkermansia muciniphilaBacteroides fragilisBacteroides stercoris +5 more PubMed ↗
Randomized trial Journal of hepatology · 2021 Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial. Patel VC, Lee S, McPhail MJW, et al. Veillonella atypica PubMed ↗
Nature communications · 2026 Pharmabiotics, Phocaeicola dorei, ameliorates cholestatic liver fibrosis by alleviating macrophage efferocytosis of neutrophils. Eom JA, Park IG, Hyun JY, et al. Phocaeicola dorei PubMed ↗
Pathogens · 2026 Novel Insights on Clinical Outcomes Using Integrated Shotgun Metagenomic Profiling of the Gut Microbiome, Resistome, and Host Immune-Inflammatory Response in Hospitalized Patients with Decompensated Cirrhosis. Philips CA, Oommen TT, Theruvath AH, et al. Ligilactobacillus salivarius PubMed ↗
Nature microbiology · 2025 Microbial collagenase activity is linked to oral-gut translocation in advanced chronic liver disease. Jin S, Cenier A, Wetzel D, et al. Veillonella parvula PubMed ↗
Liver transplantation · 2025 Baseline oral microbiome associated with post-living donor liver transplant early complications within 6 months. Babu R, Kaur M, Sharma S, et al. Klebsiella pneumoniae PubMed ↗
Clinical laboratory · 2025 Ruminococcus Gnavus Infection Detected in Ascites Fluid in a Patient with Cirrhosis. Xie Y, Wang X, Yan X, et al. Mediterraneibacter gnavus PubMed ↗
Acta microbiologica et immunologica Hungarica · 2025 Changes in intestinal microbiota and abnormal amino acid metabolism lead to neurotransmitter disorders in patients with liver cirrhosis. Gao X, Zhou K, Li S Escherichia coli PubMed ↗
Life sciences · 2025 Phocaeicola plebeius oral treatment improve fibrosis by reversing cirrhosis-related hepatic gene dysregulation. Sharma SP, Cha MG, Kwon GH, et al. Phocaeicola plebeius PubMed ↗